. Progress on progranulin. Arch Neurol. 2010 Feb;67(2):145-7. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on Primary Papers and News

  1. We have evidence for a role of fractalkine in the pathophysiology of frontotemporal dementia in progranulin (PGRN) mutation carriers. In addition, PGRN upregulates several cell adhesion molecules in cortical neurons at seven days in vitro, and promotes neurite length under excitotoxic conditions (Merino et al., submitted).

    Interestingly, a loss of function of TDP-43 that represses CDK6 expression may result from altered subcellular TDP-43 distribution in lymphoblasts (Alquezar et al., 2011).

    References:

    . Progranuline promotes repair in cortical neurons in vitro under excitotoxic conditions in vitro. Tissue Engineering Part A; Volume: 17 Issue 3-4: January 29, 2011; Merino et al. Submitted

    . Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia. Neurobiol Aging. 2012 Feb;33(2):429.e7-20. PubMed.

    View all comments by Jose Joaquin Merino

This paper appears in the following:

News

  1. Genetics of FTD: New Gene, PGRN Variety, and a Bit of FUS